Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdita Food Regs Regulatory News (EFID)

  • There is currently no data for EFID

Edita's repricing strategy

23 Mar 2022 08:44

RNS Number : 7391F
Edita Food Industries S.A.E.
23 March 2022
 

Edita Food Industries announces additional price increases in bakery and wafer segments

 

Cairo, 23 March 2022

Edita Food Industries S.A.E. (EFID.CA on the Egyptian Exchange and EFID.L on the London Stock Exchange), a leader in the Egyptian packaged snack food market, announced today that it has instituted further price increases at its bakery and wafer segments. Bakery products previously priced at EGP 4.0 per pack have been repriced at EGP 5.0 per pack, while most bakery products priced at EGP 5.0 per pack have been repriced at EGP 7.0 per pack. Meanwhile, Freska wafer bars priced at EGP 2.0 per pack have been repriced at EGP 3.0 per pack.

 

-Ends-

 

 

 

About Edita Food Industries S.A.E.

Edita, founded in 1996 and headquartered in Egypt, is a leader in the growing Egyptian packaged snack food market. The Company manufactures, markets and distributes a range of branded baked snack products including packaged cakes, bakery, rusks (baked wheat), wafers and biscuits as well as selected confectionary/candy products. The Company's local brand portfolio includes household names such as Todo, Molto, Bake Rolz, Bake Stix, Freska, Oniro and MiMix. The Company also has the exclusive ownership of the international HTT brands Twinkies, Hoho's and Tiger Tail in Egypt, Libya, Jordan, Palestine, Morocco, Algeria, Tunisia, Syria, Lebanon, Iraq, Bahrain, Oman, the UAE, Kuwait, Qatar and Saudi Arabia; and is party to a technical assistance and know-how agreement to manufacture 11 additional HTT brands across its territories. The Company holds strong number-one market positions in its core cake and bakery segments as well as in candy, a number-two market position in rusks and a growing market position in the wafers segment. In FY2021, the Company derived 94.1% of its revenue from Egypt and 5.9% from regional export markets. Learn more at ir.edita.com.eg.

Contacts

Ms. Menna Shams El Din

Head of Investor Relations

T: +202 3851-6464 | M: +2010 0 154 2428 | menna.shamseldin@edita.com.eg

Forward-Looking Statements

This communication contains certain forward-looking statements. A forward-looking statement is any statement that does not relate to historical facts and events, and can be identified by the use of such words and phrases as "according to estimates", "aims", "anticipates", "assumes", "believes", "could", "estimates", "expects", "forecasts", "intends", "is of the opinion", "may", "plans", "potential", "predicts", "projects", "should", "to the knowledge of", "will", "would" or, in each case their negatives or other similar expressions, which are intended to identify a statement as forward-looking. This applies, in particular, to statements containing information on future financial results, plans, or expectations regarding business and management, future growth or profitability and general economic and regulatory conditions and other matters affecting the Company.

Forward-looking statements reflect the current views of the Company's management ("Management") on future events, which are based on the assumptions of the Management and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. The occurrence or non-occurrence of an assumption could cause the Company's actual financial condition and results of operations to differ materially from, or fail to meet expectations expressed or implied by, such forward-looking statements.

The Company's business is subject to a number of risks and uncertainties that could also cause a forward-looking statement, estimate or prediction to differ materially from those expressed or implied by the forward-looking statements contained in this prospectus. The information, opinions and forward-looking statements contained in this communication speak only as at its date and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this communication.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFIFSTVIIVFIF
Date   Source Headline
27th Aug 20258:36 amRNSEdita- EGM Invitation
20th Aug 20257:29 amRNSEdita Announcement on 2nd Tranche Distribution
11th Aug 20254:08 pmRNSEdita Board Resolutions dated 11 August 2025
11th Aug 20254:08 pmRNSEdita reports 2Q2025
30th Jul 20252:05 pmRNSEdita Announcement
23rd Jul 20257:00 amRNSEdita Board Resolutions dated 21 July 2025
21st Jul 20257:02 amRNSEdita Board Resolutions dated 20 July 2025
27th May 20257:00 amRNSEdita Board Resolutions dated 26 May 2025
27th May 20257:00 amRNS1st Quarter Results
20th May 20253:28 pmRNSEdita announcement the distribution of free shares
6th May 20257:00 amRNSEdita Board Resolutions dated 5 May 2025
23rd Apr 20256:28 pmRNSEdita IFRS Financial Statements 31-12 2024
16th Apr 20253:53 pmRNSEdita EGM Resolutions dated 2025
9th Apr 20253:24 pmRNSEdita - Announcement on Dividend Distribution
7th Apr 20257:00 amRNSEdita OGM Resolutions dated 6 April 2025
24th Mar 20257:00 amRNSEdita EGM Invitation Scheduled 16 April 2025
13th Mar 20257:09 amRNSEdita OGM Invitation dated 6 April 2025
13th Mar 20257:00 amRNSEdita Board Resolutions Dated March 13, 2025
10th Mar 20257:00 amRNSEdita Board Resolutions Dated 9 March 2025
10th Mar 20257:00 amRNSEdita reports FY2024
20th Jan 20257:00 amRNSEdita Board Resolutions dated 16 Jan 2025
20th Jan 20257:00 amRNSEdita - Iraq Partnership
25th Nov 20244:33 pmRNSEdita Report 3Q2024
25th Nov 20244:18 pmRNSEdita Board Resolutions 3Q2024 dated 25 Nov. 2024
11th Nov 20241:01 pmRNSDividend Announcement
11th Nov 20247:00 amRNSEdita signs toll manufacturing agreement withMIFAD
7th Nov 20249:06 amRNSEdita's Board Resolutions dated 6 November 2024
7th Nov 20248:59 amRNSEdita's OGM Resolutions
21st Oct 20249:25 amRNSEdita's OGM Invitation 6 November 2024
14th Oct 20242:51 pmRNSEdita's Board Resolutions dated 14 October 2024
13th Aug 20243:36 pmRNSEdita reports 2Q2024
13th Aug 20243:34 pmRNSEdita Board Resoluations dated 13 August 2024
30th Jul 20241:36 pmRNSEdita's Board Resolutions dated 30 July 2024
9th Jul 202411:20 amRNSResignation of Mr. Hassan Elkhatib
13th Jun 20248:39 amRNSEdita's Board Resolutions dated 12 June 24
23rd May 202412:48 pmRNSEdita Financial Statements-IFRS
20th May 20244:12 pmRNSEdita Board Resolution 1Q2024
20th May 20244:07 pmRNSEdita Reports 1Q2024
20th May 20247:00 amRNSEdita's board resolutions
13th May 20247:00 amRNSEdita signed a loan agreement
22nd Apr 202412:26 pmRNSEdita's IFRS financials-FY2023
4th Apr 20249:12 amRNSDividends Announcement
2nd Apr 20247:00 amRNSOGM Resolution
11th Mar 20248:52 amRNSNomination of OGM details
6th Mar 20247:00 amRNSEdita's OGM Invitation
4th Mar 20247:00 amRNSEdita's Board Resolution
4th Mar 20247:00 amRNSEdita FY2023 Results
21st Dec 202312:54 pmRNSEdita's Disclosure
27th Nov 20239:54 amRNSEGM minutes
13th Nov 20237:00 amRNSDistribution of dividends

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.